Vascular Graft Market Research by Raw Material (Polyester Grafts, EPTFE Grafts, Polyurethane Grafts, Biosynthetic Grafts), Indication (Endovascular Aneurysm Repair, Peripheral Vascular Repair, Hemodialysis Access), End-user (Hospitals, Ambulatory Surgical Centers), and Region- Forecast till 2032

Global Vascular Graft Market Overview

According to market research future, the Vascular Graft Market would increase USD 5.9 billion at a CAGR of 7% between 2023 and 2032. Vascular graft or vascular bypass is a surgical procedure that reroutes blood from one location of normal blood flow to another area of generally normal blood flow in order to bypass a damaged artery. Depending on the indication and the raw materials used to produce the graft, there are many vascular grafts available. Vascular grafts are utilized to provide hemodialysis access as well as to treat aneurysms, especially thoracic aneurysms, endovascularly.

The high incidence of abdominal aneurysms, the expanding geriatric population, and the rising prevalence of smoking and other aneurysm risk factors are the key drivers driving the growth of this market. These illnesses include atherosclerosis, pulmonary embolism, deep vein thrombosis, and other heart ailments, as well as a growth in the number of hospitals and surgery centers, which makes disease detection and treatment easier.

Vascular Graft Market Segment Insights

The global vascular graft market has been segmented on the basis of raw material, indication, end-user, and region.

Based on raw material, the global market of vascular graft has been segmented into polyester grafts, EPTFE grafts, polyurethane grafts, and biosynthetic grafts. While polyester grafts hold the major market share among all the segments, biosynthetic graft is considered to be the fastest growing segment.

Based on indication, the global market of vascular graft has been segmented into endovascular aneurysm repair, peripheral vascular repair, and hemodialysis access. Endovascular aneurysm repair is considered to be the major segment among all the segments. The peripheral vascular repair segment is expected to be the fastest growing segment.

Based on end-user, the global market of vascular graft has been segmented into hospitals and ambulatory surgical centers. Among these, the hospitals hold the major segment and are anticipated to maintain its dominance during the review period. The ambulatory surgical centers are the fastest growing segment across the globe.

Vascular Graft Market Regional Insight

The global vascular graft market span across four major regions, namely Americas, Europe, Asia-Pacific, and Middle East & Africa.

America dominates the global vascular graft market and is anticipated to maintain its dominance over the assessment period. The growth is attributed to the high prevalence of cardiovascular diseases, diabetes, and chronic kidney diseases. With the availability of state-of-the-art healthcare infrastructure and presence of reimbursement coverage, the market is set to flourish. Asia Pacific is presumed to register the fastest market growth owing to the growing prevalence of diabetes and cardiovascular diseases in this region. Also improving healthcare infrastructure and epidemiological transition which has resulted in high rate of premature death is anticipated to trigger the demand for minimally invasive grafting procedures.

Key companies in the market of vascular graft include

• Cardinal Health (US)


• Gore Medical (US)


• Terumo (Japan)


• C. R. Bard (US)


• Medtronic (Ireland)


• LeMaitre Vascular (US)


• B. Braun Melsugen AG (Germany)


• Endologix (US)


• Maquet (Germany)


• Cook Medical (US)

Recent Development

Cardinal Health Inc (Cardinal Health) is an integrated healthcare product and service provider. It sells branded and generic pharmaceuticals, specialty medications, over-the-counter healthcare, and consumer items, medical equipment, surgical instruments, and laboratory equipment. It also runs nuclear pharmacies and cyclotrons and develops its own private label medicinal and surgical items. Its expertise is divided into four categories: logistics, product, business, and patient solutions. The corporation has operations in the United States, Canada, Europe, etc. Cardinal Health is based in Dublin, Ohio, in the United States.

Vascular Graft Raw Material Outlook

• Polyester Grafts


• EPTFE Grafts


• Polyurethane Grafts


• Biosynthetic Grafts

Vascular Graft Indication Outlook

• Endovascular Aneurysm Repair


• Peripheral Vascular Repair


• Hemodialysis Access

Vascular Graft End User Outlook

• Hospitals


• Ambulatory Surgical Centers

Vascular Graft Region Outlook

• Americas


• Europe


• Asia Pacific


• Middle East & Africa

Research Methodology

Data analysts at Market Research Future ensure objective analysis of the market while preparing market research reports by engaging set of standards which allow a comprehensive view of the market and its several components. Several factors comprising economic growth, government expenditure, supply channels and distribution channels have been scrutinized effort to relay precise information. Also, market-size estimation and validation use top-down and bottom-up approaches in order to obtain data from the demand and supply side. Analysis of data have been performed by using research framework suited to the specific industry. The frameworks are developed by the MRFR team which serves as a research standard that provides tools to create dependable market reports.

Report Attribute/Metric	Details
Market Size	2032: USD 5.9 Billion
CAGR	7% CAGR (2023-2032)
Base Year	2021
Forecast Period	2023-2032
Historical Data	2020
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Raw material, Indication, End-user
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Cardinal Health (US), Gore Medical (US), Terumo (Japan), C. R. Bard (US), Medtronic (Ireland), LeMaitre Vascular (US), B. Braun Melsugen AG (Germany), Endologix (US), Maquet (Germany), and Cook Medical (US).
Key Market Opportunities	·  High treatment cost·  Complications related to prosthetic grafts
Key Market Drivers	·  Increasing prevalence of cardiac diseases, end-stage renal diseases·  Growing prevalence of diabetes, coronary artery diseases, cardiac aneurysms, and hypertension